Form D · Other
NowRx, Inc.
Mountain View, CA · CIK 0001702206
Offering snapshot reported May 10, 2018 · SEC filing
- Reported sold
- $3.4M Offering amount: $3.4M
- Investors reported
- 54 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 25, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 10, 2018 | Initial | $3,400,651 | No comparison | 54 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-312109
Source: Form D, filed May 10, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cary Breese | Director, Executive |
| Barry Karlin | Director |
| Sumeet Sheokand | Director |
Issuer details
Industry: Other (See others in industry)
Address:
2224 Old Middlefield Way, Suite J
Mountain View, CA, 94043
Mountain View, CA, 94043